Boehringer Ingelheim India has appointed Vani Manja as Managing Director and Head of Human Pharma, effective January 1, 2021. Vani succeeds Sharad Tyagi, who retired from Boehringer Ingelheim India on December 31, 2020, the company said. In the role, Vani will assume responsibility for the company’s businesses in India, Bangladesh, Nepal and Sri Lanka. She…
Cipla Limited and Boehringer Ingelheim India Pvt. Ltd. (BI) announced that they have entered into a partnership to co-market three new oral anti-diabetics drugs Oboravo (Empagliflozin), Oboravo Met (Empagliflozin+Metformin) and Tiptengio (Empagliflozin+Linagliptin) in India. As per the International Diabetes Federation, India is home to 77 million adults aged between 20 and 79 years with diabetes,…